Digital Storytelling and Mother's Knowledge and Attitudes Towards Newborn Screning

March 2, 2026 updated by: Gizem Deniz Büyüksoy, Kirsehir Ahi Evran Universitesi

The Effect of Health Education Supported by Digital Storytelling on Maternal Knowledge and Attitudes Towards Newborn Screening

The aim of this study is to examine the effect of health education supported by digital storytelling on mothers' knowledge and attitudes towards newborn screening. It is a single-blind, controlled-group, randomized controlled experimental study. The hypotheses of the study are:

H0: Health education supported by digital storytelling has no effect on mothers' knowledge and attitudes towards newborn screening.

H1: Health education supported by digital storytelling has an effect on mothers' knowledge and attitudes towards newborn screening. Participants will:

  • Be 28-32 weeks pregnant
  • Be able to speak and understand Turkish
  • Use a smartphone with internet access

Study Overview

Status

Not yet recruiting

Detailed Description

The study will first obtain a list of pregnant women registered with each family physician at the family health centers in city center. This list will include the pregnant women's names, surnames, ages, and contact information. The pregnant women forming the research group will be contacted using the phone numbers obtained from the family health centers. After explaining the subject and importance of the study, they will be asked if they are willing to participate. The list forming the research group will be updated to include only those who volunteer for the study. Then, as a pre-test, an introductory information form and the Maternal Knowledge and Attitudes Towards Newborn Screening Scale will be administered to the individuals in the research group. After the pre-test is completed, the pregnant women in the research group will be assigned to experimental and control groups using stratified randomization according to their age. For this purpose, the pregnant women will be divided into two strata: those aged 18-35 and those over 35. After stratification, four blocks of eight people each were created, forming two separate groups, using the website randomizer.org.

Blinding In the study, the randomization process will be performed by someone other than a member of the research team, ensuring blinding. The experimental and control groups will be coded as A and B, ensuring statistical blinding as the statistician analyzing the data will not know whether the pregnant women are in the experimental or control group. Furthermore, participants will not be informed whether they are in the experimental or control group, ensuring participant blinding. Since the intervention will be performed by the researcher, researcher blinding was not possible. Thus, assignment bias, statistical bias, and reporting bias were prevented.

Outcomes Measures The outcome criterion in the study is the level of knowledge and attitude towards newborn screening. The measurement tool aimed at measuring this criterion is the Maternal Knowledge and Attitude Scale Towards Newborn Screening. The pre-test will be administered through self-report at the family health centers where the interviews with pregnant women are conducted, and the post-test will be administered through face-to-face interviews after the completion of a four-week health education program supported by digital storytelling. Intervention to be Applied to the Control Group: Two interviews will be conducted with the pregnant women in the control group at family health centers, four weeks apart. The pre-test will be administered in the first interview, and the post-test in the last interview. Telephone calls will be made to participants between the first and last weeks for reminder purposes.

Data Analysis The findings of the study will be analyzed in a computer environment. Intention to Treat (ITT) analysis will be performed to complete the missing data in the final test. Paired-sample t-test and independent samples t-test will be used for continuous data showing normal distribution. McNemar test for two dependent groups and chi-square test for two independent groups will be applied to categorical variables.

Study Type

Interventional

Enrollment (Estimated)

128

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being 28-32 weeks pregnant
  • Being able to speak and understand Turkish
  • Using a smartphone with internet access

Exclusion Criteria:

  • Not having previously given birth to a live child/Being a first-time mother
  • Having a diagnosed or suspected congenital disease in the baby
  • The pregnant woman having a vision or hearing problem

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Participants in this arm will receive the structured health education supported by digital storytelling program consisting of 4 sessions delivered over 4 weeks. The program includes health education, face-to-face interview and digital storytelling related to newborn screening. Sessions will be conducted by trained personnel according to a standardized protocol.
The health education program, supported by digital storytelling, to be applied to the experimental group is a four-week program. Sessions will be held face-to-face at family health centers one week apart. Telephone calls will be made during the first week to remind participants or inform them about their appointments. Four stories were created for the digital storytelling-supported health education program for the experimental group, using the website www.storyjumper.com. The first story covers the purpose and scope of newborn screenings, the second the testing process and possible outcomes, the third the definition of diseases and treatment options, and the fourth the parents' right to information and responsibility to participate in screenings.
No Intervention: Control Group
Participants in this arm will not receive the intervention program. They will continue with usual activities and/or standard care during the study period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal Knowledge and Attitude Scale Towards Newborn Screening
Time Frame: Four weeks
The outcome criterion in this study is the level of knowledge and attitudes towards newborn screening. The measurement tool aimed at measuring this criterion is the Maternal Knowledge and Attitude Scale Towards Newborn Screening. The pre-test will be administered through self-report at family health centers where interviews are conducted with pregnant women, and the post-test will be administered through face-to-face interviews after the completion of a four-week health education program supported by digital storytelling.
Four weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

August 31, 2026

Study Registration Dates

First Submitted

February 24, 2026

First Submitted That Met QC Criteria

March 2, 2026

First Posted (Actual)

March 5, 2026

Study Record Updates

Last Update Posted (Actual)

March 5, 2026

Last Update Submitted That Met QC Criteria

March 2, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2025-18/240

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Digital Storytelling

Clinical Trials on HEALTH EDUCATION SUPPORTED BY DIGITAL STORYTELLING

Subscribe